Md. Lokman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Md. Lokman has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Saad Ahmed Sami
Department of Pharmacy, Faculty of Biological Sciences, University of Chittagong, Chattogram 4331, Bangladesh
2 shared publications - Al Mamun
Department of Pharmacy, Faculty of Science, University of Rajshahi, Rajshahi 6205, Bangladesh
1 shared publication - Anwarul Haque
Department of Pharmacy, Faculty of Science University of Rajshahi Rajshahi Bangladesh
1 shared publication - Ariful Islam
Department of Pharmacy, School of Science and Technology, Varendra University, Rajshahi 6204, Bangladesh
1 shared publication - Ashikur Rahman
Department of Pharmacy, School of Science and Technology, Varendra University, Rajshahi 6204, Bangladesh
1 shared publication Ashraful Alam
Department of Pharmacy, Faculty of Biological Sciences University of Chittagong Chittagong Bangladesh
1 shared publication
Latest Publications
- Open Access
- 19 November 2025
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (11)
Deciphering the Antioxidant and Neuropharmacological Effects of Methanolic Extract of Artocarpus chama Leaves and Its n‐Hexane and Ethyl Acetate Fractions: GC – MS Analysis, Experimental, and In Silico Investigations
Artocarpus chama , a widely known fruit‐bearing plant in Asia and locally referred to as Chapalish in Bangladesh, has been traditionally used for various medicinal purposes. However, its neuropharmacological potential remains largely unexplored in current scientific literature. This research aims to investigate the in vitro antioxidant and in vivo neuropharmacological properties of the methanolic extract of A. chama leaves (MEAC) along with its n‐hexane (NHAC) and ethyl acetate (EAAC) fractions. The DPPH assay revealed strong antioxidant activity, with MEAC displaying an IC₅₀ of 24.30 ± 1.04 μg/mL, while NHAC and EAAC showed IC₅₀ values of 45.18 ± 2.4 μg/mL and 30.46 ± 1.15 μg/mL, respectively. In in vivo models, MEAC, NHAC, and EAAC exhibited significant anxiolytic effects in the elevated plus maze and hole‐board test at both doses (200 and 400 mg/kg). Notable sedative effects were observed in the open field test at 200 and 400 mg/kg doses, but only in the hole cross test at the 400 mg/kg dose. Additionally, all three extracts demonstrated significant antidepressant activity in behavioral despair tests at all investigated doses. GC–MS analysis identified a total of 40 phytoconstituents, several of which exhibited notable binding affinities to key drug target proteins involved in oxidative stress, anxiety, sedation, and depression, as shown through molecular docking studies. Furthermore, ADMET predictions supported their drug‐likeness and favorable pharmacokinetic and toxicity profiles. These findings suggest that A. chama leaves may serve as a promising source of bioactive compounds with neuropharmacological potential. However, further extensive studies are warranted.
- 19 November 2025
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (11)
Open AccessDeciphering the Antioxidant and Neuropharmacological Effects of Methanolic Extract of Artocarpus chama Leaves and Its n‐Hexane and Ethyl Acetate Fractions: GC – MS Analysis, Experimental, and In Silico Investigations
Artocarpus chama , a widely known fruit‐bearing plant in Asia and locally referred to as Chapalish in Bangladesh, has been traditionally used for various medicinal purposes. However, its neuropharmacological potential remains largely unexplored in current scientific literature. This research aims to investigate the in vitro antioxidant and in vivo neuropharmacological properties of the methanolic extract of A. chama leaves (MEAC) along with its n‐hexane (NHAC) and ethyl acetate (EAAC) fractions. The DPPH assay revealed strong antioxidant activity, with MEAC displaying an IC₅₀ of 24.30 ± 1.04 μg/mL, while NHAC and EAAC showed IC₅₀ values of 45.18 ± 2.4 μg/mL and 30.46 ± 1.15 μg/mL, respectively. In in vivo models, MEAC, NHAC, and EAAC exhibited significant anxiolytic effects in the elevated plus maze and hole‐board test at both doses (200 and 400 mg/kg). Notable sedative effects were observed in the open field test at 200 and 400 mg/kg doses, but only in the hole cross test at the 400 mg/kg dose. Additionally, all three extracts demonstrated significant antidepressant activity in behavioral despair tests at all investigated doses. GC–MS analysis identified a total of 40 phytoconstituents, several of which exhibited notable binding affinities to key drug target proteins involved in oxidative stress, anxiety, sedation, and depression, as shown through molecular docking studies. Furthermore, ADMET predictions supported their drug‐likeness and favorable pharmacokinetic and toxicity profiles. These findings suggest that A. chama leaves may serve as a promising source of bioactive compounds with neuropharmacological potential. However, further extensive studies are warranted.
- Open Access
- 1 January 2025
- Published by Wiley in Scientifica
- Vol. 2025 (1) , 6516268
Unveiling Pharmacological Promise of Mangifera indica (Haribhanga) Peel Extract: Exploring an Untapped Cultivar Through Biochemical and Computational Approaches
The Haribhanga is one of the most renowned varieties of mango native to the Rangpur region of Bangladesh. The study aimed to explore the in vitro and in vivo pharmacological potentialities of the methanolic extract of Mangifera indica (Haribhanga) (MEMI) peel. The antioxidant, antimicrobial, and antiarthritic activities of MEMI peel were conducted by the 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) free radical scavenging, disc diffusion, and protein denaturation assays, respectively. The extract was administered to STZ‐induced diabetic mice for 7 days for the observation of blood glucose, body weight, lipid profile, and liver enzyme levels. The gas chromatography–mass spectrometry (GC–MS) analysis was performed to identify phytochemicals in the extract. Subsequently, molecular docking was conducted to predict the binding affinity of the identified compounds. The MEMI peel exhibited notable antioxidant potentiality with an IC 50 value of 4.43 ± 0.68 μg/mL and antimicrobial activity against Bacillus cereus with a zone of inhibition of 20.67 ± 1.52 mm. Furthermore, MEMI peel demonstrated substantial antiarthritic activity, with the highest inhibition of denaturation of protein (88%) observed at the highest dose (500 μg/mL). In the in vivo experiments, MEMI peel led to a significant increase in high‐density lipoprotein ( p < 0.001, p < 0.05), with a significant decrease in blood glucose ( p < 0.001), triglycerides, total cholesterol, and low‐density lipoprotein ( p < 0.0001) in STZ‐induced diabetic mice. Comparing the diabetic control mice, the MEMI peel substantially decreased ( p < 0.001) the high serum levels of aspartate aminotransferase and alanine aminotransferase. Moreover, the extract significantly improved the body weight ( p < 0.001) of diabetic mice after 7 days of treatment. GC‐MS analysis identified 28 bioactive compounds, primarily fatty acid esters in the MEMI peel. Di‐n‐octyl phthalate, terpinen‐4‐ol, 8,11,14‐docosatrienoic acid methyl ester, and phenol, 2‐methoxy‐4‐(2‐propenyl)‐acetate exhibited the most favorable binding potential in molecular docking studies. The results suggest that MEMI peel possesses antimicrobial, antiarthritic, antidiabetic, antihyperlipidemic, and liver enzyme protective activities as a promising antioxidant.
- 1 January 2025
- Published by Wiley in Scientifica
- Vol. 2025 (1) , 6516268
Open AccessUnveiling Pharmacological Promise of Mangifera indica (Haribhanga) Peel Extract: Exploring an Untapped Cultivar Through Biochemical and Computational Approaches
The Haribhanga is one of the most renowned varieties of mango native to the Rangpur region of Bangladesh. The study aimed to explore the in vitro and in vivo pharmacological potentialities of the methanolic extract of Mangifera indica (Haribhanga) (MEMI) peel. The antioxidant, antimicrobial, and antiarthritic activities of MEMI peel were conducted by the 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) free radical scavenging, disc diffusion, and protein denaturation assays, respectively. The extract was administered to STZ‐induced diabetic mice for 7 days for the observation of blood glucose, body weight, lipid profile, and liver enzyme levels. The gas chromatography–mass spectrometry (GC–MS) analysis was performed to identify phytochemicals in the extract. Subsequently, molecular docking was conducted to predict the binding affinity of the identified compounds. The MEMI peel exhibited notable antioxidant potentiality with an IC 50 value of 4.43 ± 0.68 μg/mL and antimicrobial activity against Bacillus cereus with a zone of inhibition of 20.67 ± 1.52 mm. Furthermore, MEMI peel demonstrated substantial antiarthritic activity, with the highest inhibition of denaturation of protein (88%) observed at the highest dose (500 μg/mL). In the in vivo experiments, MEMI peel led to a significant increase in high‐density lipoprotein ( p < 0.001, p < 0.05), with a significant decrease in blood glucose ( p < 0.001), triglycerides, total cholesterol, and low‐density lipoprotein ( p < 0.0001) in STZ‐induced diabetic mice. Comparing the diabetic control mice, the MEMI peel substantially decreased ( p < 0.001) the high serum levels of aspartate aminotransferase and alanine aminotransferase. Moreover, the extract significantly improved the body weight ( p < 0.001) of diabetic mice after 7 days of treatment. GC‐MS analysis identified 28 bioactive compounds, primarily fatty acid esters in the MEMI peel. Di‐n‐octyl phthalate, terpinen‐4‐ol, 8,11,14‐docosatrienoic acid methyl ester, and phenol, 2‐methoxy‐4‐(2‐propenyl)‐acetate exhibited the most favorable binding potential in molecular docking studies. The results suggest that MEMI peel possesses antimicrobial, antiarthritic, antidiabetic, antihyperlipidemic, and liver enzyme protective activities as a promising antioxidant.